Skip to content

serial monitoring of quantitative c reactive protein in sepsis

SERIAL QUANTITATIVE CRP CONCENTRATIONS DURING INITIAL ANTIBIOTIC THERAPY IN NEONATAL SEPSIS: A NESTED CASE CONTROL STUDY

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2011/11/002101
Enrollment
129
Registered
2011-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Newborns with suspected sepsis

Interventions

Intervention1: CRP: Serial qCRP in Culture positive who happened to have received sensitive antibiotic versus culture positive who happened to have received resistant antibiotics versus culture steril

Sponsors

Postgraduate institute of Medical Education and Reasearch
Lead Sponsor
Dr Praveen Kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Infants from 0-28 days of life admitted in Newborn Unit of PGIMER with 1. Clinically suspected sepsis, AND 2. Whose quantitative CRP (qCRP) prior to start of antibiotics is > 10 mg/L.

Exclusion criteria

Exclusion criteria: The following patients will be excluded: Subjects who have 1. Undergone surgery in the previous 7 days 2. Birth trauma 3. Major or life-threatening congenital malformations 4. Clinically suspected or serologically proven intra-uterine infection 5. Antibiotics in preceding 48 hours, unless those antibiotics happened to be proven resistant

Design outcomes

Primary

MeasureTime frame
A) Key outcome: Quantitative CRP at 48 hours. Timepoint: 48 hr from enrollment

Secondary

MeasureTime frame
Secondary outcomes: 1. Quantitative CRP at 24 and 36 hr. 2. SNAP-II score remission category at 48 hours.Timepoint: 48 hours from enrollment

Countries

India

Contacts

Public ContactDr sandeep S Patil

PGIMER

drpkumarpgi@gmail.com09914208308

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026